Tokunaga M, Loranger J M, Wu H C
J Biol Chem. 1983 Oct 25;258(20):12102-5.
Based on the rationale that Escherichia coli cells containing increased levels of prolipoprotein signal peptidase would be highly resistant to globomycin, a specific inhibitor of the prolipoprotein signal peptidase, we have isolated a clone from the Carbon-Clarke collection, plasmid pLC3-13, which is globomycin-resistant and contains an increased level of prolipoprotein signal peptidase activity. The plasmid pMT521, a subclone of pLC3-13 in pBR322, conferred on its host cells approximately 20 times overproduction of prolipoprotein signal peptidase and an extremely high level of resistance against globomycin. The overproduced prolipoprotein signal peptidase was completely inhibited by the presence of globomycin in the in vitro assay, and the overproduced activity was found in the cell envelope fraction. Several lines of biochemical and genetic evidence suggest that the gene contained in pLC3-13 and its derivative clones is most likely the structure gene (lsp) for prolipoprotein signal peptidase.
含有增加水平的前脂蛋白信号肽酶的大肠杆菌细胞对球霉素(前脂蛋白信号肽酶的一种特异性抑制剂)具有高度抗性,我们从Carbon-Clarke文库中分离出一个克隆,即质粒pLC3-13,它对球霉素具有抗性,并且含有增加水平的前脂蛋白信号肽酶活性。质粒pMT521是pLC3-13在pBR322中的一个亚克隆,赋予其宿主细胞约20倍过量产生的前脂蛋白信号肽酶以及对球霉素的极高抗性。在体外测定中,过量产生的前脂蛋白信号肽酶被球霉素完全抑制,并且过量产生的活性存在于细胞包膜部分。几条生化和遗传学证据表明,pLC3-13及其衍生克隆中包含的基因很可能是前脂蛋白信号肽酶的结构基因(lsp)。